Publicacións nas que colabora con José Antonio Oteo Revuelta (23)

2023

  1. Beyond the effects of HIV infection and integrase inhibitors-based therapies on oral bacteriome

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. IGF1R is a mediator of sex-specific metabolism in mice: Effects of age and high-fat diet

    Frontiers in Endocrinology, Vol. 13

  2. Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome

    Scientific Reports, Vol. 12, Núm. 1

  3. Integrase Inhibitors Partially Restore Bacterial Translocation, Inflammation and Gut Permeability Induced by HIV Infection: Impact on Gut Microbiota

    Infectious Diseases and Therapy, Vol. 11, Núm. 4, pp. 1541-1557

  4. Severity of COVID-19 attributable to obesity according to BMI and CUN-BAE

    Semergen, Vol. 48, Núm. 8, pp. 6

2021

  1. ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study

    Frontiers in Endocrinology, Vol. 12

  2. Corrigendum: ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study (Frontiers in Endocrinology, (2021), 12, (688071), 10.3389/fendo.2021.688071)

    Frontiers in Endocrinology

  3. La investigación frente al SARS-COV-2 y la COVID-19 en el Departamento de Enfermedades Infecciosas del Hospital Universitario San Pedro-CIBIR

    Zubía, Núm. 39, pp. 63-73

  4. Lights and shadows of microbiota modulation and cardiovascular risk in HIV patients

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 13

  5. Response to Letter to the Editor from Abobaker and Darrat: "circulating levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients"

    Journal of the Endocrine Society

  6. The influence of interferon β–1b on gut microbiota composition in patients with multiple sclerosis

    Neurologia, Vol. 36, Núm. 7, pp. 495-503

2020

  1. Autologous fecal transplantation from a lean state potentiates caloric restriction effects on body weight and adiposity in obese mice

    Scientific Reports, Vol. 10, Núm. 1

  2. The Impact of Human Immunodeficiency Virus Infection on Gut Microbiota α-Diversity: An Individual-level Meta-analysis

    Clinical Infectious Diseases, Vol. 70, Núm. 4, pp. 615-627

2019

  1. Characterization of gut microbiota composition in HIV-infected patients with metabolic syndrome

    Journal of Physiology and Biochemistry, Vol. 75, Núm. 3, pp. 299-309

  2. Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients

    European Journal of Internal Medicine, Vol. 67, pp. 47-58

2015

  1. Efectos de los principales hongos cultivados en La Rioja en adipocitos humanos en cultivo

    Zubía, Núm. 33, pp. 41-58

2014

  1. Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 7, pp. 1903-1910

2013

  1. Multiple frequency bioimpedance is an adequate tool to assess total and regional fat mass in HIV-positive patients but not to diagnose HIV-associated lipoatrophy: A pilot study

    Journal of the International AIDS Society, Vol. 16

  2. Role of mitochondria in HIV infection and associated metabolic disorders: Focus on nonalcoholic fatty liver disease and lipodystrophy syndrome

    Oxidative Medicine and Cellular Longevity

2012

  1. Investigación en VIH y Lipodistrofia en el Hospital San Pedro-Cibir: modelos "in vitro" de adipocitos para el estudio de los efectos tóxicos de fármacos antirretrovirales

    Zubía, Núm. 24, pp. 129